Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
MetadataShow full item record
Ponnusamy , S , He , Y , Hwang , D-J , Thiyagarajan , T , Houtman , R , Bocharova , V , Sumpter , B G , Fernandez , E , Johnson , D , Du , Z , Pfeffer , L M , Getzenberg , R H , McEwan , I J , Miller , D D & Narayanan , R 2019 , ' Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer ' , Clinical Cancer Research , vol. 25 , no. 22 , pp. 6764-6780 . https://doi.org/10.1158/1078-0432.CCR-19-1458
This manuscript has been accepted for publication in Clinical Cancer Research, which is published by the American Association for Cancer Research.
Showing items related by title, author, creator and subject.
The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study Busby, John; Karasneh, Reema; Murchie, Peter; McMenamin, Úna; Gadalla, Shahinaz M.; Camargo, M. Constanza; Iversen, Lisa; Lee, Amanda J.; Spence, Andrew D.; Cardwell, Chris R. (2020-01)
Major ethnic group differences in breast cancer screening uptake in Scotland are not extinguished by adjustment for indices of geographical residence, area deprivation, long-term illness and education Bansal, N.; Bhopal, R. S.; Steiner, M. F. C.; Brewster, D. H.; Scottish Health and Ethnicity Linkage Study (2012-04-10)
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia Craig, Stephanie G.; Humphries, Matthew P; Alderdice, Matthew; Bingham, Victoria; Richman, Susan D.; Loughrey, Maurice B.; Coleman, Helen G; Viratham-Pulsawatdi, Amelie; McCombe, Kris; Murray, Graeme I.; Blake, Andrew; Domingo, Enric; Robineau, James; Brown, Louise; Fisher, David; Seymour, Matthew T.; Quirke, Phil; Bankhead, Peter; McQuaid, Stephen; Lawler, Mark; McArt, Darragh G.; Maughan, Tim S.; James, Jacqueline A; Salto-Tellez, Manuel (2020-10-13)